Welcome to the Society for Clinical Trials

A Message from 2017-2018 SCT President, Theodore G. Karrison, PhD

2017-2018 SCT President, Theodore G. Karrison, PhD

Hello! I am privileged to serve as your President and to welcome both new and old members to the Society. The Society for Clinical Trials (SCT) is a scientific, educational, and charitable organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing clinical trial professionals. We accomplish this mission through our annual scientific meeting, which includes invited and contributed sessions, poster presentations, and educational short courses and workshops; our highly regarded journal Clinical Trials; our ongoing webinar series; and our many outreach activities. The Society is currently in its 39th year and our members come from academia, industry, government and non-profit research and advocacy groups. We are a multidisciplinary society consisting of clinical investigators, biostatisticians, project managers, IT specialists, clinical research associates and other specialists engaged in the design, conduct, and analysis of clinical trials. We are a truly international organization, as evidenced by our 2017 annual meeting, which was co-sponsored by the MRC Hubs Network and held in Liverpool, England. We also sponsor the SCT-QSPI (Quantitative Sciences in the Pharmaceutical Industry) workshop, which is held biannually in the Washington, DC area. This workshop brings together statisticians and other specialists from industry, the U.S. FDA, and academia.


Beyond total treatment effects in randomised controlled trials: Baseline measurement of intermediate outcomes needed to reduce confounding in mediation investigations

How to construct an optimal interim report: What the data monitoring committee does and doesn’t need to know

Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST)

Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?

Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of Family Therapy vs. Treatment as Usual in adolescents following self-harm

A Bayesian basket trial design using a calibrated Bayesian hierarchical model

The reporting of harms in publications on randomized controlled trials funded by the “Programme Hospitalier de Recherche Clinique,” a French academic funding scheme

Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders

Increasing the use of mobile technology–derived endpoints in clinical trials

Adaptive parametric prediction of event times in clinical trials

Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials

Use of online recruitment strategies in a randomized trial of cancer survivors

Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture

Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials

Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs

Academic chartered data safety committees versus industry sponsored data safety committees: The need for different recommendations

SCT RSS Subscription  Subscribe RSS


SCT Newsletter

SCT Newsletter Current Issue (vol 18):
President's Corner, Workshops, Seminars, Committee Updates, Webinars, Annual Meeting Promotion, Upcoming Events and more...
  Download Feb 2018 Issue »

David Sackett Trial of the Year

SCT Trial of the Year Award
10th Annual Award (2016)
“Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis (ORATORIO)”
Read Full Press Release »

SCT Brochure

SCT Newsletter Society for Clinical Trials
An international professional organization dedicated to the theory and practice of clinical trials.
 Download Brochure »